MOC Director and Professor
My research interests include post-marketing drug safety addressing the health and economic impacts of adverse drug events, drug shortages and interchangeability of therapeutic alternatives, and appropriateness of prescription and utilization patterns of pharmaceuticals, particularly, opioid...
